Back to top

Citrullinated Human Fibrinogen

Product Overview

Arginine residues in the terminal clotting factor fibrinogen, which is present in high concentrations in blood, can be converted to citrulline residues by peptidylarginine deiminase 4 (PAD4). Antibodies capable of recognizing citrullinated proteins, including citrulliunated fibrinogen, are found in the majority of patients with rheumatoid arthritis (RA).  Immunization of mice with PAD4-citrullinated human fibrinogen has been reported to induce an arthritis that resembles human RA .


Zhao, X., Okeke, N.L., Sharpe, O., et al. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Research & Therapy 10(4), (2008).

Saraiva AL, Peres RS, Veras FP, Talbot J, de Lima KA, Luiz JPM, Cunha TM, Louzada-Junior P, Cunha FQ, Alves-Filho JC. Citrullinated human fibrinogen triggers arthritis through an inflammatory response mediated by IL-23/IL-17 immune axis. Int Immunopharmacol. 2021 Dec;101(Pt B):108363. doi: 10.1016/j.intimp.2021.108363. Epub 2021 Nov 19. 

Hill, J.A., Al-Bishri, J., Gladman, D.D., et al. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis. Journal of Rheumatology 33(11), 2115-2119(2006).

Jonathan A. Hill, David A. Bell, William Brintnell, David Yue, Bret Wehrli, Anthony M. Jevnikar, David M. Lee, Wolfgang Hueber, William H. Robinson, Ewa Cairns; Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice . J Exp Med 14 April 2008; 205 (4): 967–979. doi:

Spec Sheet